« Back to Record
Wells, A. U., Flaherty, K. R., Brown, K., Inoue, Y., Devaraj, A., Richeldi, L., Moua, T., Crestani, B., Wuyts, W., Stowasser, S., Quaresma, M., Goeldner, R. G., Schlenker-Herceg, R., Bondue, B., INBUILD trial investigators,, & Kolb, M. (2020). Nintedanib in patients with progressive fibrosing interstitial lung diseases-subgroup analyses by interstitial lung disease diagnosis in the INBUILD trial: a randomised, double-blind, placebo-controlled, parallel-group trial. The Lancet. Respiratory medicine, 8(5), 453-460. doi:10.1016/S2213-2600(20)30036-9
Citation APA
Permalink
Permalink
http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/305426



